Baxter Bros Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.73M Buy
4,774
+131
+3% +$134K 0.66% 37
2026
Q1
$4.27M Sell
4,643
-213
-4% -$216K 0.53% 44
2025
Q4
$5.22M Sell
4,856
-320
-6% -$306K 0.6% 38
2025
Q3
$3.95M Buy
5,176
+3,942
+319% +$2.93M 0.46% 45
2025
Q2
$962K Sell
1,234
-920
-43% -$715K 0.12% 88
2025
Q1
$1.78M Sell
2,154
-3
-0.1% -$2.5K 0.23% 67
2024
Q4
$1.67M Buy
2,157
+179
+9% +$148K 0.22% 70
2024
Q3
$1.75M Buy
1,978
+20
+1% +$18K 0.23% 72
2024
Q2
$1.77M Hold
1,958
0.23% 69
2024
Q1
$1.52M Sell
1,958
-175
-8% -$125K 0.2% 72
2023
Q4
$1.24M Sell
2,133
-5
-0.2% -$2.92K 0.17% 73
2023
Q3
$1.15M Sell
2,138
-10
-0.5% -$5.15K 0.17% 73
2023
Q2
$1.01M Sell
2,148
-82
-4% -$34.4K 0.15% 79
2023
Q1
$766K Sell
2,230
-30
-1% -$10.1K 0.12% 80
2022
Q4
$827K Sell
2,260
-25
-1% -$8.86K 0.14% 76
2022
Q3
$739K Sell
2,285
-100
-4% -$31.7K 0.13% 79
2022
Q2
$773K Hold
2,385
0.14% 74
2022
Q1
$683K Hold
2,385
0.1% 83
2021
Q4
$659K Hold
2,385
0.1% 81
2021
Q3
$551K Buy
2,385
+5
+0.2% +$1.23K 0.09% 82
2021
Q2
$546K Buy
2,380
+75
+3% +$15.1K 0.09% 85
2021
Q1
$431K Hold
2,305
0.07% 90
2020
Q4
$389K Buy
+2,305
New +$344K 0.07% 91

Other funds holding LLY

Baxter Bros Inc's LLY Position: Q2 2026 in Review

Baxter Bros Inc increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $134K and bringing the position to 4,774 shares worth $5.73M. The position accounts for 0.66% of the portfolio, ranked #37.

Baxter Bros Inc first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Baxter Bros Inc held 4,774 shares of Eli Lilly worth $5.73M as of Q2 2026.
  • Baxter Bros Inc bought 131 Eli Lilly shares in Q2 2026, an estimated $134K.
  • Eli Lilly made up 0.66% of Baxter Bros Inc's portfolio in Q2 2026, its #37 holding.
  • Baxter Bros Inc first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.